New drug trial targets Hard-to-Treat hepatitis d
NCT ID NCT06649266
Summary
This study is testing whether RBD1016 injections can reduce hepatitis D virus levels in people with chronic infection. Fourteen adults will receive either the drug or a placebo for comparison, with regular checkups over 60 weeks. The main goal is to see if the treatment lowers virus levels and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS D are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Infektionskliniken, Danderyds sjukhus
Stockholm, 18288, Sweden
-
Medicinsk enhet för Infektionssjukdomar, Karolinska Universitetssjukhuset Huddinge
Stockholm, 14186, Sweden
Conditions
Explore the condition pages connected to this study.